Human recombinant soluble guanylyl cyclase: expression, purification, and regulation

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• Soluble guanylate cyclase (sGC) plays a crucial role in cellular signaling pathways.
• Efficient production of active recombinant human sGC is essential for detailed biochemical and structural studies.

Purpose of the Study:

• To coexpress and purify active human soluble guanylate cyclase (sGC) subunits using a baculovirus expression system.
• To characterize the activation and inhibition kinetics of the recombinant human sGC enzyme.

Main Methods:

• Coexpression of alpha1 and beta1 subunits of human sGC in Sf9 insect cells via baculovirus system.
• Purification of hexahistidine-tagged recombinant sGC using nickel-affinity chromatography.
• Enzyme activity assays using NO donors (sodium nitroprusside, YC-1) and inhibitors (ODQ, cGMP, pyrophosphate).

Main Results:

• Successfully produced and purified active recombinant human sGC with one heme per heterodimer.
• Demonstrated significant potentiation of sGC activity by combining sodium nitroprusside and YC-1, leading to a 2,200-fold stimulation.
• Identified inhibition of sGC activity by reaction products cGMP and pyrophosphate, with distinct binding and cooperativity characteristics.

Conclusions:

• The baculovirus system provides a robust method for producing large quantities of active human sGC.
• Understanding the kinetics and product inhibition of sGC is vital for its physiological role and therapeutic targeting.
• The availability of active recombinant enzyme facilitates future structural and functional investigations of sGC.